Foundation Model of the immune system. Building a foundation model of the immune system to power blueprints for therapeutics. Owns the world's largest proprietary immune platform with HD discovery that finds rare cells others miss, feeding a database that trains AI to turn biological complexity into de-risked drug development assets.
52%
Revenue Growth (YoY)
$8M
Previous Round
The world's largest proprietary immune platform featuring HD discovery technology that identifies rare cells others miss. The platform feeds a comprehensive database that trains AI models to transform biological complexity into de-risked drug development assets. Powers therapeutic blueprints for pharmaceutical companies and research institutions, with capabilities that grow stronger with every new client engagement.
Click to read more
Sign up for FirstGlance to follow startups, save favorites, and connect with founders.
Sign up free